Amgen to reduce price of its cholesterol drug Repatha starting 2020 Medical Dialogues Bureau3 Nov 2019 3:45 AMAmgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol Medical Dialogues Bureau10 Oct 2019 6:04 AMZydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore Farhat Nasim1 Oct 2019 8:43 AMThe company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets Medical Dialogues Bureau26 April 2019 3:29 AMPhentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol Farhat Nasim8 March 2019 4:15 AMAtorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns Medical Dialogues Bureau9 Feb 2018 5:58 AMHYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
Company to pay 35 million dollar for falsely marketing cholesterol drug Ruby Khatun Khatun25 Sept 2017 5:12 AMBOSTON: A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a...
Zydus Cadila gets USFDA nod for anti-cholesterol drug Ruby Khatun Khatun1 May 2017 4:10 AMNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market an anti-cholesterol drug, Cholestyramine, in the...
